Clin2
NCT07865364Possibly a fitNot yet recruiting

Treating chest pain in hypertrophic cardiomyopathy with a coronary sinus reducer

Hypertrophic Cardiomyopathy

Part of Heart & circulation, Pain clinical trials.

This study tests a device called a coronary sinus reducer for people with hypertrophic cardiomyopathy (a condition where the heart muscle is thickened) who still have symptoms like chest pain. The device is placed in a vein of the heart to improve blood flow and reduce symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have hypertrophic cardiomyopathy without obstruction (no blockage of blood flow out of the heart)
  • You still have symptoms like chest pain or shortness of breath despite taking current medications
  • A special heart MRI (CMR) shows areas of reduced blood flow in at least two segments of the heart
  • You are 18 years or older
  • You do not have severe kidney problems, a very weak heart pump, or a device like an ICD that would interfere with MRI

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07806149Not yet recruiting
A new catheter procedure to treat thickened heart muscle

This study tests a new, less invasive procedure called SESAME that uses a special catheter to carefully trim the thickened heart muscle wall (septum) to improve blood flow and reduce symptoms. It's for people with hypertrophic cardiomyopathy or those at risk of obstruction during mitral valve replacement.

Washington D.C., District of Columbia
NCT07120776Recruiting
PET scan study for chest pain in hypertrophic cardiomyopathy

This trial uses a special PET scan to see if the drug Mavacamten (Camzyos) helps improve blood flow to the heart muscle in people with hypertrophic obstructive cardiomyopathy (HOCM) who have chest pain or shortness of breath. If you already take Mavacamten as part of your usual care, the study will compare your PET scan results before and after treatment.

Manchester
NCT07057323Enrolling by invitation
Coronary sinus reducer for heart failure with preserved pumping function

This trial tests a device placed in a heart vein to improve symptoms in people whose heart pumps normally but still causes shortness of breath and fatigue. The device may help relieve pressure in the heart and improve daily life.

Rochester, Minnesota
NCT07485985Not yet recruiting
A device to reduce chest pain when other treatments are not possible

This trial tests a small device called a coronary sinus reducer that is placed in a vein of the heart to improve blood flow and reduce chest pain in people who still have angina despite medications and cannot have stents or bypass surgery. The procedure is done through a small tube in the groin or arm.

NCT06288165Recruiting
Sinus reducer trial for persistent chest pain

This study tests a device called the sinus reducer for people with long-lasting chest pain that hasn't improved with medication or other procedures. It may help if you have limited options for treatment.

Lubin, Lower Silesian Voivodeship
NCT04606459Recruiting
Device trial for hard-to-treat heart chest pain from small vessels

This trial tests whether a small pressure-reducing device placed in a heart vein (the coronary sinus) can reduce symptoms in people with ongoing chest pain from tiny blood vessel problems. It is for angina that has not improved despite standard heart medicines, and only if special heart tests show reversible reduced blood flow.

Mainz, Rhineland-Palatinate

Hear when a new Hypertrophic Cardiomyopathy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.